High-Intensity Statins for Secondary Prevention

JAMA Cardiol. 2017 Jan 1;2(1):55. doi: 10.1001/jamacardio.2016.4479.
No abstract available

Publication types

  • Comment

MeSH terms

  • Atherosclerosis*
  • Cardiovascular Diseases*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors*
  • Primary Prevention
  • Secondary Prevention

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors